Literature DB >> 11709435

Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter.

C D Hardin1, G Lazzarino, B Tavazzi, D Di Pierro, T M Roberts, B Giardina, M J Rovetto.   

Abstract

The extent to and the mechanism by which fructose-1,6-bisphosphate (FDP) crosses cell membranes are unknown. We hypothesized that its transport is either via band 3 or a dicarboxylate transporter. The question was addressed in isolated Langendorff rat hearts perfused under normoxic conditions. Groups of hearts received the following metabolic substrates (in mM): 5 FDP; 5 FDP + either 5, 10, or 20 fumarate; 10 FDP and either 5, 10, or 20 fumarate; or 5 FDP + 2 4,4'-dinitrostilbene-2,2'-disulfonate (DNDS), a band 3 inhibitor. FDP uptake and metabolism were measured as production of [(13)C]lactate from [(13)C]FDP or (14)CO(2) and [(14)C]lactate from uniformly labeled [(14)C]FDP in sample perfusates. During 30 min of perfusion, FDP metabolism was 12.4 +/- 2.6 and 31.2 +/- 3.0 micromol for 5 and 10 mM FDP, respectively. Addition of 20 mM fumarate reduced FDP metabolism over a 30-min perfusion period to 3.1 +/- 0.6 and 6.3 +/- 0.5 micromol for 5 and 10 mM FDP groups, respectively. DNDS did not affect FDP utilization. These data are consistent with transport of FDP by a dicarboxylate transport system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709435     DOI: 10.1152/ajpheart.2001.281.6.H2654

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Phosphate and succinate use different mechanisms to inhibit sugar-induced cell death in yeast: insight into the Crabtree effect.

Authors:  Yong Joo Lee; Elodie Burlet; Floyd Galiano; Magdalena L Circu; Tak Yee Aw; B Jill Williams; Stephan N Witt
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Characterization of the high-affinity uptake of fructose-1,6-bisphosphate by cardiac myocytes.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

3.  Fructose-1, 6-diphosphate (FDP) as a novel antidote for yellow oleander-induced cardiac toxicity: a randomized controlled double blind study.

Authors:  Indika Gawarammana; Fahim Mohamed; Steven J Bowe; Ashoka Rathnathilake; Shantha K Narangoda; Shifa Azher; Andrew H Dawson; Nick A Buckley
Journal:  BMC Emerg Med       Date:  2010-06-29

4.  Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVB-irradiated HaCaT keratinocytes.

Authors:  Soo Mi Ahn; Hyoung-Young Yoon; Byung Gon Lee; Kyoung Chan Park; Jin Ho Chung; Chang-Hyun Moon; Soo Hwan Lee
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

5.  Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats.

Authors:  Kaiping Xu; Janet L Stringer
Journal:  Pharmacol Res       Date:  2008-02-02       Impact factor: 7.658

6.  Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate.

Authors:  Marie A Schroeder; Helen J Atherton; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler
Journal:  NMR Biomed       Date:  2011-03-08       Impact factor: 4.044

7.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

8.  Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity.

Authors:  Kamal M Yakoub; Giacomo Lazzarino; Angela M Amorini; Giuseppe Caruso; Concetta Scazzone; Marcello Ciaccio; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli; Valentina Di Pietro
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

9.  Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.

Authors:  Henrique Bregolin Dias; Jarbas Rodrigues de Oliveira; Márcio Vinícius Fagundes Donadio; Shioko Kimura
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.